Science Explorer Back to mapMap
Discussion
Topic · Cardiology and Cardiovascular Medicine

Cardiovascular Disease and Adiposity

Cardiovascular Disease and Adiposity is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 40k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the role of perivascular adipose tissue in cardiovascular health, particularly its involvement in vascular function, inflammation, and the development of cardiovascular diseases such as atherosclerosis and coronary artery disease. The research explores the impact of adipocytokines, the relationship with endothelial function, and the influence of obesity on perivascular adipose tissue.

  • Perivascular Adipose Tissue
  • Epicardial Fat
  • Vascular Function
  • Inflammation
  • Cardiovascular Disease
  • Adipocytokines
  • Atherosclerosis
  • Coronary Artery Disease
  • Endothelial Function
  • Obesity
Research works
40k
fractional, since 1950
In the world top 10%
4.1k
per year above
Top-10% rate
10.3%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+23%
the tick is no change
Largest producer
United States
36% of the 10 largest, 2022-now
Cardiovascular Disease and Adiposity

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cardiovascular Disease and Adiposity research?

By volume, the United States and China publish the most (2.5k and 1.9k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.5k works
  2. 2 China 1.9k works
  3. 3 Russia 441 works
  4. 4 India 439 works
  5. 5 United Kingdom 357 works
  6. 6 Japan 354 works
  7. 7 Italy 351 works
  8. 8 Türkiye 292 works
  9. 9 Germany 238 works
  10. 10 South Korea 211 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 35.6%China: 27.0%Russia: 6.2%India: 6.1%6 others listed: 25.2%36%largest
United States2,548 · 35.6%China1,932 · 27.0%Russia441 · 6.2%India439 · 6.1%6 others listed1,803 · 25.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cardiovascular Disease and Adiposity research?

By volume in 2022-now, Harvard University publishes the most Cardiovascular Disease and Adiposity research, followed by Russian Academy of Sciences and Chinese Academy of Medical Sciences & Peking Union Medical College.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 132 works
  2. 2 Russian Academy of SciencesRussia 80 works
  3. 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 79 works
  4. 4 Capital Medical UniversityChina 75 works
  5. 5 Mayo ClinicUnited States 63 works
  6. 6 Shanghai Jiao Tong UniversityChina 63 works
  7. 7 Johns Hopkins UniversityUnited States 57 works
  8. 8 University of California, Los AngelesUnited States 49 works
  9. 9 Nanjing Medical UniversityChina 49 works
  10. 10 University of North Carolina at Chapel HillUnited States 47 works

Who are the leading researchers in Cardiovascular Disease and Adiposity?

The most-cited researchers publishing on Cardiovascular Disease and Adiposity include George Davey Smith, Ali H. Mokdad and Walter Churchill Willett.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Ali H. Mokdad United States 429k citations
  3. 3 Walter Churchill Willett United States 411k citations
  4. 4 John J.V. McMurray United Kingdom 349k citations
  5. 5 Hermann Brenner Germany 343k citations
  6. 6 Cyrus Cooper United Kingdom 342k citations
  7. 7 Emelia J. Benjamin United States 341k citations
  8. 8 Valery L. Feigin New Zealand 341k citations
  9. 9 Jun Wang China 340k citations
  10. 10 Stephan Windecker Switzerland 338k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cardiovascular Disease and Adiposity?

The most cited paper in Cardiovascular Disease and Adiposity is "Obesity is associated with macrophage accumulation in adipose tissue" (Stuart Phillip Weisberg, Daniel McCann, Manisha Desai et al., 2003), with 8,604 citations. Next come "The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function" (8,505) and "Bariatric Surgery" (6,822).

Most cited papers
#PaperReleasedCitations
1 Obesity is associated with macrophage accumulation in adipose tissue Stuart Phillip Weisberg, Daniel McCann, Manisha Desai et al. · Journal of Clinical Investigation Open access 15 Dec 2003 8,604
2 The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function Gijs H. Goossens · Obesity Facts Open access 2017 8,505
3 Bariatric Surgery Hēnry Buchwald, Yoav Avidor, Eugene Braunwald et al. · JAMA 12 Oct 2004 6,822
4 Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Sherif F. Nagueh, Otto Armin Smiseth, Christopher P. Appleton et al. · Journal of the American Society of Echocardiography Open access 30 Mar 2016 6,811
5 Prevalence of Diagnosed Atrial Fibrillation in Adults Alan S. Go, Elaine M. Hylek, Kathleen A. Phillips et al. · JAMA 9 May 2001 6,255
All 100 most cited papers, with filters and sorting

Where is Cardiovascular Disease and Adiposity research done?

The largest centres of Cardiovascular Disease and Adiposity research in 2022-now are Beijing (China), Shanghai (China), Moscow (Russia) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Kemerovo.

Largest cities, 2022-now

  1. 1 BeijingChina 303 works
  2. 2 ShanghaiChina 161 works
  3. 3 MoscowRussia 142 works
  4. 4 BostonUnited States 129 works
  5. 5 SeoulSouth Korea 123 works
  6. 6 LondonUnited Kingdom 122 works
  7. 7 New YorkUnited States 99 works
  8. 8 GuangzhouChina 97 works
  9. 9 TokyoJapan 88 works
  10. 10 NanjingChina 85 works

Where it is the local speciality

  1. KemerovoRU · 22.0 works16×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cardiovascular Disease and Adiposity than the world average.

See Cardiovascular Disease and Adiposity on the map

Where is the best place to study Cardiovascular Disease and Adiposity?

Among universities, judged by research, Harvard University, Chinese Academy of Medical Sciences & Peking Union Medical College and Johns Hopkins University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.53%fractional works in this field (log) →share of work in the world top 10% →Chinese Academy of M…Harvard UniversityKarolinska InstitutetJohns Hopkins Univer…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 87.716.8%4.5×132 +73.3%
2Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 72.618.9%8.1×79 +83.7%
3Johns Hopkins UniversityUnited States 67.713.0%4.0×56 +27.0%
4Karolinska InstitutetSweden 65.413.5%4.8×25 +50.8%
5University of ZurichSwitzerland 63.822.5%2.5×16 +28.3%
6Shanghai Jiao Tong UniversityChina 63.216.7%2.4×63 +62.8%
7University of California, Los AngelesUnited States 62.511.9%4.7×49 +51.7%
8University of WashingtonUnited States 62.518.6%2.1×22 +130.0%
9Northwestern UniversityUnited States 62.318.5%3.4×26 +42.0%
10Nanjing Medical UniversityChina 61.214.9%5.9×48 +58.1%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cardiovascular Disease and Adiposity, country by country

Is Cardiovascular Disease and Adiposity research growing?

Output in 2022-2025 was 23% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cardiovascular Disease and Adiposity.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cardiovascular Disease and Adiposity as a percentage of every work published that year, 0.047% in 2024.

still counting0.020%0.040%0.060%Cardiovascular Disease and Adiposity0.045% in 202519801990200020102020

Fractional works of Cardiovascular Disease and Adiposity over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cardiovascular Disease and Adiposity10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cardiovascular Disease and Adiposity. Posts are plain text and can be reported.